Latest Breaking News On - Halsin partners - Page 1 : comparemela.com

Addex to Present at the Swiss Biotech Day 2024

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will.

United statesMike sinclairTim dyerJanssen pharmaceuticals incCongress centerSwiss exchangeSwiss biotech dayAddex therapeuticsJanssen pharmaceuticalsAmerican depositary sharesExecutive officerHalsin partnersForward looking statementsPrivate securities litigation reform actAddex therapeutic annual reportAddex therapeutic

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesTim dyerMike sinclairMikhail kalinichevSwiss exchangeJanssen pharmaceuticals incRelease full yearHost conference callAddex therapeuticsTranslational scienceConference callParticipant dial inJanssen pharmaceuticalsAmerican depositary sharesExecutive officerHalsin partners

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Addex Reports Q3 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesTim dyerMikhail kalinichevMike sinclairSwiss exchangeProvides corporateHoc announcement pursuantAddex therapeuticsFinancial dataFinancial statementsCall detailsChief executive officerTranslational scienceConference callParticipant dial inAmerican depositary shares

Addex Therapeutics to Release Third Quarter 2023 Financial

Geneva, Switzerland, November 23, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric.

United statesTim dyerMike sinclairMikhail kalinichevSwiss exchangeThird quarterTranslational scienceAddex therapeuticsRelease third quarterProvides corporate updateConference callParticipant dial inAmerican depositary sharesExecutive officerHalsin partnersSwiss stock exchange adxn

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

Geneva, Switzerland, November 23, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that that.

United statesTim dyerMike sinclairMikhail kalinichevSwiss exchangeThird quarterTranslational scienceAddex therapeuticsRelease third quarterProvides corporate updateConference callParticipant dial inAmerican depositary sharesExecutive officerHalsin partnersForward looking statements